In my experience working with people tracking their results on GLP-1 class drugs, the first month is more about appetite suppression kicking in than the drug running at full power
Month 23: Metabolic and Hormonal Adaptations GLP-1 improves insulin response, helping prevent energy crashes and intense hunger spikes, especially helpful for patients with insulin resistance
People began calling their results "remarkable" and "life-changing." Over time, LifeWave conducted multiple clinical studies on X39, including double-blind trials measuring things like copper peptide levels in the blood, brain coherence via EEG scans, and improvements in sleep and recovery markers
These stories create momentum and confidence in the program
PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) analyzes genetic variants in appetite-regulating pathways, including GLP1R rs6923761 and MC4R rs17782313, which influence how your body responds to GLP-1 medications
doi:10.1111/cns.12490 Ji WW, Li RP, Li M, et al